Pmcb benefits 0 from the legalization of MJ. That's a fact. University of Colorado has secured a schedule 1 license for pmcb to play with MJ already. Legalizing MJ on a fed basis will only take away pmcb exclusivity. Fact.
$PMCB = Caveat Emptor Buyer Beware [color=red]Our success depends in large part on our ability to obtain and maintain patent protection in the U.S. and other countries with respect to our proprietary technology and products. We seek to protect our proprietary position by filing patent applications in the U.S. and abroad related to our novel technologies and product candidates. Our patent portfolio includes patents and patent applications we exclusively licensed from Bavarian Nordic/GSF, SG Austria, Austrianova and UTS. Two of our U.S. patents and nine of our foreign patents, each of which covers capsules encapsulating a cell expressing cytochrome P450 and treatment methods using the same, will expire on March 27, 2017. We cannot at this time estimate the financial or other impact of the expiration of these patents.
I can 100% loss!! and btw the nda's are between pmcb and Bavarian Nordic/GSF, SG Austria, Austrianova and UTS. NOT BIG PHARMA as some dream.
The patent prosecution and/or patent maintenance process is expensive and time-consuming. We may not be able to file and prosecute or maintain all necessary or desirable patent applications or maintain the existing patents at a reasonable cost or in a timely manner. We may choose not to seek patent protection for certain innovations and may choose not to pursue patent protection in certain jurisdictions. Under the laws of certain jurisdictions, patents or other intellectual property rights may be unavailable or limited in scope. It is also possible that we will fail to identify patentable aspects of our discovery and preclinical development output before it is too late to obtain patent protection.
Pmcb is broke as it is. Sure wont be able to afford protecting their last asset...
Moreover, in some circumstances, we do not have the right to control the preparation, filing and prosecution of patent applications, or to maintain the patents, covering technology that we license from third parties. Therefore, these patents and applications may not be prosecuted and enforced in a manner consistent with the best interests of our business.
Fair warning gotta give Kenny boy that. Now who will heed it??
News 
Market Data 
Discover 
